KMDA News and Press, Kamada Ltd. From 12/08/25

Based on the Results of a Planned Interim Futility Analysis the Inhaled AAT Trial is Unlikely to Demonstrate a Statistically Significant Benefit in its Primary Endpoint K amada Continues to Supply GLASSIA®, its AAT-IV Treatment, Marketed Internationally Including in the U.S. and ...

By Meg Flippin Benzinga DETROIT, MICHIGAN - November 18, 2025 ( NEWMEDIAWIRE ) - Kamada Ltd. (NASDAQ: KMDA), a global biopharmaceutical company and a global leader in specialty plasma-derived therapeutics, posted double-digit revenue and adjusted EBITDA growth for the third quarter and reiter...

2025-11-10 10:51:37 ET Kamada Ltd. (KMDA) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Amir London - Chief Executive Officer Chaime Orlev - Chief Financial Officer Conference Call Participants Brian Ritchie - Lifesci Advisors...

2025-11-10 07:17:39 ET More on Kamada Kamada: Earnings Expansion Cycle With Embedded Margin Of Safety Kamada Ltd. (KMDA) Q2 2025 Earnings Call Transcript Kamada Q3 2025 Earnings Preview Kamada GAAP EPS of $0.13 beats by $0.04, revenue of $44.75M misses by $1....

Third Quarter Revenues of $ 47 . 0 Million, up 13 % Year-over-Year, and Adjusted EBITDA of $11. 7 Million, up 34 % Year-Over Year Nine Month Revenue of $135. 8 Million, up 11% Year-over-Year; Adjusted EBITDA of $ 34 ...

VEON Ltd. (VEON) is expected to report $1.21 for Q3 2025 eToro Group Ltd. (ETOR) is expected to report $0.52 for Q3 2025 KE Holdings Inc American Depositary Shares (each representing three Class A) (BEKE) is expected to report $0.09 for Q3 2025 CoreWeave Inc. (CRWV) is expected to rep...

2025-11-09 18:00:29 ET Major earnings expected before the bell on Monday include: Organon & Co. ( OGN ) Starwood Property Trust ( STWD ) Tyson Foods ( TSN ) Global Ship Lease ( GSL ) EVgo ( EVGO ) Read the full article on Seeking Alpha ...

2025-11-07 12:27:17 ET More on Kamada Kamada: Earnings Expansion Cycle With Embedded Margin Of Safety Kamada Ltd. (KMDA) Q2 2025 Earnings Call Transcript Kamada GAAP EPS of $0.13 beats by $0.04, revenue of $44.75M misses by $1.78M Kamada Q2 2025 Earnings Prev...

REHOVOT, Israel, and HOBOKEN, N.J. , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced ...

REHOVOT, Israel and HOBOKEN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, t...